Details checkedClinical trial listing onlyHistorical/discontinuedCheckedregistry

Oticon Medical Ponto BHX Implant System study

Also known as: Ponto BHX Implant System study, Ponto Biohelix Implant System, Ponto BHX, Abbreviated Profile of Hearing Aid Benefit (APHAB), Glasgow Benefit Inventory (GBI), Doc-00066211, NCT04310202

Oticon Medical

Primary source

Company

Oticon Medical

Program Type

Device

Modality

Cochlear/Auditory Implant

Stage

Observational/NA

Status

Completed

Target Gene

—

Route / Mode

Bone-anchored hearing implant / percutaneous abutment

Confidence

84%

Status Confidence

Status needs checking

Evidence Strength

Needs more support

Last Reviewed

2026-06-09

Geography

Denmark, Spain, United Kingdom

Population

adult, bone-anchored-hearing-system, implantable-device, hearing-loss

Trial IDs

Mechanism

Percutaneous bone-anchored hearing system using the Ponto BHX implant and skin-penetrating abutment; the sound processor transmits vibration through skull bone to the inner ear.

Indications

Hearing Loss

Notes

ClinicalTrials.gov identifies this as an Oticon Medical-funded observational study of successful bone-anchored hearing system use after implantation of the Ponto Biohelix/Ponto BHX Implant System. APHAB and GBI are patient questionnaires used as study measures, not the product or program. No posted registry results were available in this pass.

Evidence & Sources

2 structured sources

clinicaltrials

Supports: canonicalName, aliases, company, programType, modality, mechanism, indications, stage...

IDs: NCT04310202, Doc-00066211, Ponto BHX Implant System, Ponto Biohelix, APHAB, GBI

Open

company

Supports: allCompanies, notes

IDs: Oticon Medical, Demant, Hearing Implants

Open

Key Events

2020-03-17